Home » Global Pharma Eyes China as Patents End, Costs Rise
Global Pharma Eyes China as Patents End, Costs Rise
Western drug companies, struggling with expiring patents, a dwindling pipeline of new drugs and burgeoning costs, are looking to Asia’s vast markets for new ideas, partnerships and customers.
News Center
News Center
Upcoming Events
-
07May
-
14May
-
30May